The log-rank test showed that cumulative HCC recurrence was significantly higher in patients whose post-treatment AFP was ≥6.0 ng/mL than in patients whose post-treatment AFP was < 6.0 ng/mL (p = 0.040, Fig. 3a). This evidence concerns the gene AFP and hepatocellular carcinoma.